Literature DB >> 2078412

Expression of HTLV-I envelope protein fused to hydrophobic amino-terminal peptide of baculovirus polyhedrin in insect cells and its application for serological assays.

H Nyunoya1, T Ogura, M Kikuchi, H Iwamoto, K Yamashita, M Maekawa, Y Takebe, K Miyamura, S Yamazaki, K Shimotohno.   

Abstract

The envelope of human T-cell leukemia virus type I (HTLV-I) consists of two glycoproteins gp46 and p20E. Recombinant envelope proteins were produced by using an expression vector derived from insect baculovirus, Bombyx mori nuclear polyhedrosis virus. Polyhedrin fusion proteins C182, N147, and N287 contained whole region p20E, C-terminal half of gp46, and almost whole region gp46, respectively. N147 and N287 were suggested to be processed forms resulting from internal cleavage by cellular enzymes. In cultured cells and the insect larvae, C182 and N147 were produced abundantly enough to be purified to homogeneity; however, N287 was produced poorly and not purified. The purified proteins were recognized by HTLV-I-infected human sera and shown to be highly specific antigens for blood screening systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078412     DOI: 10.1089/aid.1990.6.1311

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

Authors:  J Arp; M LeVatte; J Rowe; S Perkins; E King; C Leystra-Lantz; S K Foung; G A Dekaban
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

2.  Isolation of cDNAs for DNA-binding proteins which specifically bind to a tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I.

Authors:  A Tsujimoto; H Nyunoya; T Morita; T Sato; K Shimotohno
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.

Authors:  S Kushida; H Mizusawa; M Matsumura; H Tanaka; Y Ami; M Hori; K Yagami; T Kameyama; Y Tanaka; A Yoshida
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.

Authors:  R B Lal; S Brodine; J Kazura; E Mbidde-Katonga; R Yanagihara; C Roberts
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.